Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00608062 · ClinicalTrials.gov registry record · NA
Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 155
- Enrollment target
NCT00608062 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 155 participants.
The verdict
NCT00608062, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 155 participants
- Enrollment target
Study Summary
The purpose of this study is to find out why women's arteries stiffen as they go through menopause, and how this is affected by estrogen loss. We believe that arteries stiffen with the loss of estrogen because of "oxidative stress," the production of molecules that can damage cells and tissues in the body, and because the arteries lose their ability to expand, or dilate.
Interventions
- DRUG Transdermal placebo patch
- DRUG GnRHant - Ganirelix acetate
- DRUG Transdermal estradiol patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2007-03 |
| Est. Completion | 2012-10-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00608062
The ClinicalTrials.gov registry entry for NCT00608062 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 155 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Transdermal placebo patch is the first listed.
NCT00608062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00608062 about?
NCT00608062 is a clinical study titled "Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women". The purpose of this study is to find out why women's arteries stiffen as they go through menopause, and how this is affected by estrogen loss. We believe that arteries stiffen with the loss of estrogen because of "oxidative stress," the production of molecules that can damage cells and tissues in th...
What is the current status of trial NCT00608062?
This trial is currently completed. It is a NA study. The enrollment target is 155 participants. The study started on 2007-03. Estimated completion is 2012-10-25.
What interventions are being tested in trial NCT00608062?
The interventions under investigation include: Transdermal placebo patch (DRUG), GnRHant - Ganirelix acetate (DRUG), Transdermal estradiol patch (DRUG).
Who is sponsoring clinical trial NCT00608062?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.